This inventor holds 1 USPTO granted patent. Top assignee: Medtronic Ireland Manufacturing Unlimited Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Neidert: Innovator in Neuromodulation Therapy
Introduction
Michael Neidert is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of neuromodulation therapy, focusing on systems and methods that enhance patient care. His innovative approach aims to improve the efficacy of neuromodulation treatments.
Latest Patents
Neidert holds a patent for "Systems and methods for assessing the efficacy of neuromodulation therapy." This patent outlines a method that involves positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient. The method includes delivering neuromodulation energy at the target site and obtaining measurements related to the dimensions of the renal blood vessel. These measurements can be compared to baseline measurements to assess the therapy's efficacy. This innovative approach has the potential to transform how neuromodulation therapy is evaluated and applied in clinical settings. He has 1 patent to his name.
Career Highlights
Michael Neidert is currently employed at Medtronic Ireland Manufacturing Unlimited Company, where he continues to develop and refine his innovative ideas. His work at Medtronic places him at the forefront of medical technology, contributing to advancements that can significantly impact patient outcomes.
Collaborations
Neidert has collaborated with notable colleagues such as Paul John Coates and Robert Melder. These partnerships have likely fostered an environment of innovation and creativity, enhancing the development of new technologies in the field.
Conclusion
Michael Neidert's contributions to neuromodulation therapy exemplify the impact of innovation in healthcare. His work not only advances medical technology but also holds the promise of improving patient care and treatment efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile